[ET Net News Agency, 14 October 2026] HANSOH PHARMA (03692) fell 3% to HK$30.6.
It hits an intra-day low of HK$30.56, hitting an 1-month low, and an intra-day high of HK$31.62. The total shares traded was 3.36 million, with a value of HK$104.07m. The active buy/sell ratio is 52:48, with net buying turnover of HK$4.49m. CITIGROUP GLOBAL accounts for greatest net responsive buying turnover of HK$6.75m, with volume weighted average price of HK$30.964. GOLDMAN SACHS (ASIA) SEC accounts for greatest net responsive selling turnover of HK$4.46m, with volume weighted average price of HK$30.932. The stock has fallen a combined 3% over the past 2 consecutive trading days.
The Hang Seng Index now rose 73 points, or 0.3% to 24,418; the Hang Seng China Enterprises Index now rose 32 points, or 0.4% to 8,207.
Basic Information| Nominal | 30.600 | % Chg | -2.98% |
| High | 31.620 | Low | 30.560 |
| Shares Tr | 3.36m | Turnover | 104.07m |
| 10-D SMA | 32.936 | %H.V | 36.473 |
| 20-D SMA | 33.550 | VWAP | 30.957 |
| 50-D SMA | 33.611 | RSI14 | 34.617 |
Status: Hitting an 1-month low, active buy/sell ratio is 52:48, with net buying turnover of HK$4.49m, falling a combined 3% over the past 2 consecutive trading days
Performance of stocks in the same sector or of relevance| Stock (Code) | Price (HK$) | Change (%) |
|---|
| HANSOH PHARMA (03692) | 30.600 | -2.98 |
| SIHUAN PHARM (00460) | 0.715 | -0.69 |
| GRAND PHARMA (00512) | 4.765 | +1.28 |
| SBP GROUP (01177) | 5.165 | -3.46 |
| HENGRUI PHARMA (01276) | 46.400 | -0.56 |
| LIVZON PHARMA (01513) | 21.160 | +0.02 |
| LUYE PHARMA (02186) | 1.710 | Unchanged |
| FOSUN PHARMA (02196) | 17.310 | -1.14 |
| SH PHARMA (02607) | 11.220 | +1.08 |
| CHINARES PHARMA (03320) | 4.575 | +1.67 |
(ed)
Nominal 
